Flavia A. Martins
Uberlandia, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Subversion strategies of lysosomal killing by intracellular pathogens.
Journal: Microbiological research
Published: July 16, 2023
Nanocarriers From Natural Lipids With In Vitro Activity Against Campylobacter jejuni.
Journal: Frontiers in cellular and infection microbiology
Published: June 09, 2020
The Recombinant Protein Based on Trypanosoma cruzi P21 Interacts With CXCR4 Receptor and Abrogates the Invasive Phenotype of Human Breast Cancer Cells.
Journal: Frontiers in cell and developmental biology
Published: June 04, 2020
The Recombinant Form of Trypanosoma cruzi P21 Controls Infection by Modulating Host Immune Response.
The Recombinant Form of Trypanosoma cruzi P21 Controls Infection by Modulating Host Immune Response.
Journal: Frontiers in immunology
Published: February 29, 2020
Experimental evidences that P21 protein controls Trypanosoma cruzi replication and modulates the pathogenesis of infection.
Journal: Microbial pathogenesis
Published: May 06, 2019
Galectin-3: A Friend but Not a Foe during Trypanosoma cruzi Experimental Infection.
Journal: Frontiers in cellular and infection microbiology
Published: May 16, 2017
A high throughput analysis of cytokines and chemokines expression during the course of Trypanosoma cruzi experimental oral infection.
Journal: Acta tropica
Published: September 20, 2015
Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy.
Journal: Scientific reports
Published: November 26, 2014
A recombinant protein based on Trypanosoma cruzi P21 enhances phagocytosis.
Journal: PloS one
Published: April 12, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026